Skip to content

Evaluation of the human body efficacy of JINGSHENGSE compact light grain essence and JINGSHENGSE plastic face lifting face cream.

Evaluation of the human body efficacy of JINGSHENGSE compact light grain essence and JINGSHENGSE plastic face lifting face cream.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083851
Enrollment
Unknown
Registered
2024-05-06
Start date
2024-05-06
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin aging

Interventions

Experimental group:During the test period, the test samples provided by the test institution must be used at the test site, and any other cosmetics, functional foods, health products, drugs or medical

Sponsors

Cosmetics Testing Center, Dermatology Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) From 25 to 55 years old, Asian (China), healthy female or male; (2) The residence is the location of the testing institution; (3) Sensitive muscle classification questionnaire was assessed as sensitive muscle and had a positive lactic acid tingling test (3 points); (4) The face has a certain degree of eye lines (level 3 and above), crow's feet (level 3 and above), head lines (level 2 and above), Sichuan lines (level 1 and above), mouth lines (level 1 and above), law lines (level 2 and above), (wrinkle classification refer to the skin aging map (Volume 2 Asian)); (5) Facial skin relaxation; (6) Able to understand the test process, volunteer to participate in the test and sign the written informed consent.

Exclusion criteria

Exclusion criteria: (1) The application of any topical drug at the test site within the last two months; (2) Using antihistamines in the past week or immunosuppressants in the last month; (3) Patients with inflammatory skin disease; (4) Patients with insulin-dependent diabetes mellitus; (5)Patients with asthma or other chronic respiratory diseases under treatment; (6) Those who have received anti-cancer chemotherapy in the past six months; (7) Patients with immunodeficiency or autoimmune diseases; (8) Women born during pregnancy or lactation; (9) Significant scar, pigmentation, atrophy, bright red nevus, sunburn, wounds, wear, in or near the skin test site Tattoo or other defects that may affect the determination of the test results; (10) In the past three months, those who have received photorejuvenation, laser and other medical and aesthetic treatments or other facial beautification methods that may affect the skin condition; (11) Participated in similar facial tests, oral drug trials or other clinical trials in the past 2 months; (12) Highly sensitive physique, known allergic to cosmetics or daily chemical ingredients, alcohol, rubber or drugs; (13) Those who need to be exposed to outdoor daylight for a long time due to work or other reasons; (14) Other iatrogenic problems may affect the test results (such as coagulopathy, severe hyperglycemia, high Blood pressure, hyperlipidemia, mental illness or other major diseases); (15) Non-volunteer participants or those who cannot complete the prescribed trial content as required.

Design outcomes

Primary

MeasureTime frame
Self-assessment of subject;Facial image uptake and analysis;Image analysis of facial wrinkles;The measurement of skin elasticity ;

Secondary

MeasureTime frame
Lactic acid stinging test;The measurement of skin firmness;

Countries

China

Contacts

Public ContactYe Li

Dermatology Hospital of Southern Medical University

dlpfbyy@163.com+86 153 6066 6806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026